Profile
TIVC ABT BSX-PA SYK BSX MDT
Company Name Tivic Health Systems, Inc. Abbott Laboratories Boston Scientific Corporation Stryker Corporation Boston Scientific Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $2.38M $183.08B $175.45B $126.35B $110.15B $100.91B
Employees 0.01K 114.00K 45.00K 52.00K 48.00K 95.00K
CEO Ms. Jennifer Ernst Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Michael F. Mahoney Mr. Geoffrey Straub Martha
Ratings
TIVC ABT BSX-PA SYK BSX MDT
Quant Rating Score 3 1 3 1 3
Quant Rating Neutral Strong Sell Neutral Strong Sell Neutral
Trading
TIVC ABT BSX-PA SYK BSX MDT
Last Close $0.452 $105.24 $122.18 $331.67 $74.92 $78.7
High 52 $3.09 $120.98 $122.18 $358.71 $78.59 $88.51
Low 52 $0.04 $90.19 $122.18 $253.85 $48.64 $69.43
Price vs. 52 Week High -85.37 % -13.01 % 0 % -7.54 % -4.67 % -11.08 %
Price vs. 52 Week Low 1030 % 16.69 % 0 % 30.66 % 54.03 % 13.35 %
Total Return
TIVC ABT BSX-PA SYK BSX MDT
1 Month Return 14.72 % 0.56 % 0 % -2.6 % -2.7 % -0.79 %
3 Month Return -56.54 % -2.13 % 0 % -1.17 % 2.39 % -1.3 %
6 Month Return -66.27 % -6.04 % 0 % 6.52 % 22.56 % -9.06 %
9 Month Return -64.96 % 13.34 % 0 % 26.64 % 51.29 % 13.35 %
YTD Return -74.89 % -4.39 % 0 % 10.76 % 29.6 % -4.47 %
1 Year Return 833.88 % -6.58 % 0 % 17.61 % 42.33 % -11.08 %
3 Year Return 0 % -12.16 % 0 % 0 % 64.62 % -39.56 %
5 Year Return 0 % 18.85 % 0 % 0 % 77.16 % -23.78 %
Dividends
TIVC ABT BSX-PA SYK BSX MDT
Dividend Yield Percentage (TTM) - 2.05 % - 0.95 % - 3.52 %
Dividend Paid and Capex Coverage Ration (TTM) -82.46 % 1.22 % 2.66 % 1.96 % 2.64 % 1.29 %
Dividend Per Share (TTM) - 2.16 % - 3.15 % - 2.77 %
Payout Ratio (TTM) - 65.2 % 6.1 % 34.48 % 0.77 % 99.73 %
Growth
TIVC ABT BSX-PA SYK BSX MDT
Asset Growth -10.28 % -1.64 % 8.21 % 8.21 % 8.21 % -1.06 %
Gross Profit Growth -6.69 % -9.7 % 14.01 % 12.78 % 14.01 % -5.14 %
Revenue Growth -36.09 % -8.12 % 12.29 % 11.11 % 12.29 % 3.64 %
Revenue 3 Year -96.03 % 18.09 % 40.06 % 41.29 % 40.06 % 8.85 %
Revenue 5 Year -91.88 % 32.35 % 37.78 % 48.53 % 37.78 % 7.41 %
Revenue 10 Year -91.88 % 63.34 % 84.02 % 126.63 % 84.02 % 43.65 %
EBIT Growth 18.35 % -22.53 % 42.09 % 36.85 % 42.09 % 4.5 %
Net Income Growth 18.34 % -17.45 % 128.22 % 34.22 % 128.22 % -2.18 %
Net Income 3 Yeari Growth Per Share 94.13 % 29.73 % 1209.43 % 95.8 % 1209.43 % 3.26 %
Net Income 5 Yeari Growth Per Share 94.24 % 143.85 % -9.39 % -12.21 % -9.39 % -19.5 %
Net Income 10 Yeari Growth Per Share 94.24 % 97.66 % 1315.23 % 213.78 % 1315.23 % -9.48 %
Operating Income Growth 18.35 % -22.53 % 42.09 % 36.85 % 42.09 % 4.5 %
Operating Cash Flow Growth (CFG) 4.57 % -24.21 % 64.02 % 41.43 % 64.02 % 12.39 %
Operating 3 Year CFG 91.83 % -6.36 % 61.83 % 12.02 % 61.83 % 10.18 %
Operating 5 Year CFG 93.27 % 16.29 % 667.41 % 40.12 % 667.41 % -1.78 %
Operating 10 Year CFG 93.27 % 94.35 % 113.53 % 96.25 % 113.53 % 3.3 %
EPS Growth 90.04 % -16.24 % 140 % 33.87 % 140 % -2.12 %
EPS Diluted Growth 90.04 % -16.62 % 137.78 % 33.71 % 137.78 % -2.13 %
Book Value Per Share -87.97 % 6.01 % 8.01 % 11.49 % 8.01 % -2.31 %
Share Holder 3 Year Equity Growth Per Share 108.83 % 19.98 % 22.65 % 40.57 % 22.65 % -1.1 %
Share Holder 5 Year Equity Growth Per Share -95.62 % 27.6 % 110.04 % 56.21 % 110.04 % 1.66 %
Share Holder 10 Year Equity Growth Per Share -95.62 % 36.45 % 172.17 % 104.97 % 172.17 % 94.93 %
Dividend Per Share Growth - 8.27 % -49.88 % 7.97 % -49.88 % 1.54 %
Dividend 3 Year Growth Per Share - 41.54 % -2.5 % 30.56 % -2.5 % 19.02 %
Dividend 5 Year Growth Per Share - 81.76 % - 59.67 % - -
Dividend 10 Year Growth Per Share - 258.71 % - 183.29 % - 147.94 %
Debt Growth -30.38 % -10.4 % 2.26 % -0.41 % 2.26 % 6.91 %
Free Cash Flow Growth 3.37 % -35.17 % 86.32 % 54.03 % 86.32 % 13.54 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 26 Apr 2024
Profitability
TIVC ABT BSX-PA SYK BSX MDT
Gross Profit Margin TTM 29.89 % 54.38 % 68.75 % 63.09 % 68.89 % 64.27 %
Return on Assets TTM -231.56 % 7.67 % 2.74 % 8.53 % 4.98 % 4.09 %
Return on Equity TTM -207.63 % 14.62 % 5.13 % 18.41 % 9.57 % 7.19 %
Return on Capital Employed TTM -331.73 % 11.64 % 6.66 % 12.73 % 8.72 % 7.09 %
Net Income Per EBT TTM 100 % 85.37 % 63.08 % 85.81 % 85.16 % 76 %
EBT Per Ebit TTM 99.99 % 95.64 % 74.52 % 94.87 % 77.39 % 86.1 %
EBIT Per Revenue TTM -671.08 % 16.71 % 14.71 % 19.7 % 18.18 % 17.36 %
Cash Flow To Debt Ratio TTM -2414.64 % 48.97 % 18.94 % 26.97 % 22.52 % 26.98 %
Receivables Turnover TTM 15.32 6.17 6.28 6.04 6.61 5.28
Payables Turnover TTM 1.45 4.45 4.7 6.21 5.14 4.8
Inventory Turnover TTM 1.03 2.72 1.99 1.54 1.85 2.22
Fixed Asset Turnover TTM 266.82 % 402.94 % 453.27 % 643.04 % 457.71 % 453.09 %
Asset Turnover TTM 34.51 % 56.2 % 39.66 % 53.2 % 41.53 % 35.97 %
Operating Cash Flow Per Share TTM -5.28 4.12 1.24 9.12 1.68 5.13
Free Cash Flow Per Share TTM -5.22 2.84 0.81 7.51 1.06 3.93
Cash Per Share TTM 113.64 % 383.55 % 39.7 % 632.75 % 276.01 % 605.38 %
Operating Cash Flow Sales Ratio TTM -683.51 % 17.54 % 13.6 % 16.55 % 16.27 % 20.97 %
Free Cash Flow Operating Cash Flow Ratio TTM 98.79 % 68.92 % 65.5 % 82.36 % 62.7 % 76.62 %
Cash Flow Coverage Ratios TTM -2414.64 % 48.97 % 18.94 % 26.97 % 22.52 % 26.98 %
Price To Free Cash Flows Ratio TTM -0.31 37.19 95 44.21 70.92 19.41
Price To Operating Cash Flows Ratio TTM -0.07 25.55 60.77 36.36 44.48 15.33
Price Cash Flow Ratio TTM -0.07 25.55 60.77 36.36 44.48 15.33
Income Statement (TTM)
TIVC ABT BSX-PA SYK BSX MDT
Revenue $0B $40.11B $14.24B $20.5B $14.24B $32.36B
Gross Profit $0B $22.13B $9.9B $13.06B $9.9B $19.45B
Gross Profit Ratio 23.72% 55.18% 69.49% 63.7% 69.49% 60.11%
EBITDA $-0.01B $10.59B $3.62B $4.95B $3.62B $8.38B
Net Income $-0.01B $5.72B $1.59B $3.17B $1.59B $3.68B
EPS Diluted -10.4 3.26 1.07 8.25 1.07 2.76
Balance Sheet (MRQ)
TIVC ABT BSX-PA SYK BSX MDT
Long Term Debt $0B $13.6B $8.96B $10.9B $8.96B $23.88B
Total Liabilities $0B $34.39B $15.61B $21.32B $15.61B $39.56B
Total Equity $0B $38.83B $19.53B $18.59B $19.53B $50.42B
Total Investments $0B $1.18B $0.41B $0.08B $0.41B $8.34B
Total Debt $0B $15.87B $9.49B $13B $9.49B $26.05B
Total Assets $0.01B $73.21B $35.14B $39.91B $35.14B $89.98B
Cash Flow Statement (TTM)
TIVC ABT BSX-PA SYK BSX MDT
Net Income $-0.01B $5.7B $1.59B $3.17B $1.59B $3.68B
Inventory $0B $-0.23B $-0.66B $-0.8B $-0.66B $-0.14B
Dividends Paid $0B $-3.56B $-0.03B $-1.14B $-0.03B $-3.67B
Operating Cash Flow $-0.01B $7.26B $2.5B $3.71B $2.5B $6.79B
Capital Expenditure $-0B $-2.2B $-0.8B $-0.58B $-0.8B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 105.24
AEMD Aethlon Medical, Inc. 0.3675
AFIB Acutus Medical, Inc. 0.031
AHCO AdaptHealth Corp. 11.22
AHPI Allied Healthcare Products, Inc. 0.5501
ALGN Align Technology, Inc. 220.45
ALUR Allurion Technologies Inc. 0.8596
AMIX Autonomix Medical, Inc. Common Stock 1.29
ANIK Anika Therapeutics, Inc. 27.9
AORT Artivion, Inc. 27.48
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 1.34
ASXC Asensus Surgical, Inc. 0.3391
ATEC Alphatec Holdings, Inc. 10.91
AVNS Avanos Medical, Inc. 23.14
AXDX Accelerate Diagnostics, Inc. 1.3
AXGN AxoGen, Inc. 9.24
AXNX Axonics, Inc. 68.49
AZYO Aziyo Biologics, Inc. 1.49
ETFs With Exposure to TIVC
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 178.79
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 135.6
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 135.6
VEMPX Vanguard Extended Market Index InstlPlus 0 334.63
Unlock